Press asco. They publish JNCCN--Journal of the National Comprehensive Cancer Network, The ASCO Post, and the Journal of the Advanced Practitioner in Oncology. Conquer Cancer ®, the ASCO Foundation, supports ASCO by funding groundbreaking research and education across cancer’s full continuum. – Research exploring the optimal timing for therapy, intensifying combination strategies, the use of AI in the clinic, and the detection of residual disease in genitourinary cancers will be featured in the 2026 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium’s official Press Program. Thomas Powles presented an updated analysis from the phase III global Through research, education, and promotion of high quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. com or fax (631) 692-0805. ASCO’s peer-reviewed journals follow a continuous publication schedule. ASCO will provide a letter stating your intent to attend the ASCO Genitourinary Cancers Symposium once you are both registered and paid in full, which may assist you in obtaining your travel visa. com) -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that data across multiple genitourinary cancers from several approved and investigational medicines will be presented at the 2026 American Society of Clinical Key data from Merck’s portfolio and pipeline to be presented at the 2026 ASCO GU Cancers Symposium: First-time data from the Phase 3 KEYNOTE-B15/EV-304 trial We drive innovation that makes the world healthier, safer, smarter and more sustainable. Learn more about abstract submission, policies, and guidelines for faculty and presenters. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author. JCO Clinical Cancer Informatics JCO CCI is an interdisciplinary and borderless journal publishing clinically relevant research based on biomedical informatics methods and processes applied to cancer-related data, information, and images. Refer to Optional Features Section for other available manual operators. “At ASCO GU, we’re pleased to share new data offering deeper insights into the performance of POSLUMA across clinically important prostate cancer settings, including results from our head-to-head comparator study, as well as additional analyses in biochemical recurrence and newly diagnosed disease,” said Marco Campione, President and CEO of Blue Earth Diagnostics. H-Series, P-Series and S-Series Snap-Action Switch Options Optional snap-action switches to meet specific electrical loads or application conditions are available on most ASCO TRI-POINT switch units. It is important that you analyze all aspects of your application and review the information concerning the product in the current product catalog. , its subsidiaries and authorized distributors provide product options for further investigation by users having technical expertise. com) The 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Annual Symposium held in San Francisco, CA between February 13–15, 2025 was host to a urothelial carcinoma rapid oral abstract session. Find the latest news releases related to ASCO’s peer-reviewed journals, scientific meetings, and public policy-related statements and initiatives, as well as information and resources for media professionals. Guidelines can address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented). Dr. The ASCO Post Staff / Tuesday, February 17, 2026 12:00 PM Cancer Surgery Outcomes Similar Between Rural and Urban Facilities Patients in rural areas who received surgery locally for their lung or colon cancer had comparable surgical outcomes and mortality rates to patients who underwent surgery in an urban facility, according to the results of an analysis published in the Journal of the Media registration: To participate in the Annual Meeting press briefings and/or register to attend the Meeting in person in Chicago, please visit ASCO’s Media Headquarters at https://mediahq. In addition to original research, JCO CCI publishes reviews, editorials, and commentaries, reporting on biomedical informatics studies relevant to cancer ASCO’s peer-reviewed journals follow a continuous publication schedule. ASCO Meetings Program Guide This page contains important information for corporate and institutional public relations professionals about ASCO Meetings, including the Annual Meeting. Learn more about the sessions, speakers, and science that will be presented at this year's meeting below. PALOMA-3 presentation of subcutaneous amivantamab and lazertinib selected to showcase cutting-edge approaches in lung cancer during prestigious "Best of ASCO" program New data showcase first- and -best-in-class, complementary multiple myeloma therapies, including DARZALEX® (daratumumab), CARVYKTI®… ASCO Clinical Practice Guidelines Clinical practice guidelines serve as a guide for doctors and outline appropriate methods of treatment and care. Learn more about ASCO's full slate of educational and scientific meetings. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. All three studies will be featured in the official ASCO GU Press Program Reno, Nevada (UroToday. Due to the variety of operating conditions and . Conquer Cancer, the ASCO Foundation, supports ASCO by funding groundbreaking research and education across cancer’s full continuum. CALL FOR ABSTRACTS 2026 ASCO Breakthrough Jun 25 - Jun 28, 2026 Online & In-Person | Singapore Submit Abstract Register Abstract Submission Deadline: February 24, 2026 Early Registration Deadline: May 20, 2026 APPLICATIONS OPEN Leadership Development Program: Central and Eastern Europe Dec 01 - Mar 11, 2026 Online & In-Person | Central and Media:Air (For vacuum or other media, consult your local ASCO sales office for details. ASCO P-Series pressure switches consist of an open frame or enclosure protected switch unit and a transducer unit. They can be ordered separately for customer stocking and/or field assembly or as a complete factory-assembled unit. About ASCO Daily News ASCO Daily News is the official conference reporter of the American Society of Clinical Oncology (ASCO), providing high-quality, unbiased research summaries and oncology news to ASCO members and oncology health care providers. Meeting-specific embargo policies and information is provided below. Attendees may request a visa letter using the link in the registration confirmation email or by logging into the registration website to review their registration. Allogene assumes no obligation to update the forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Information about the ASCO Annual Meeting for media, including registration instructions and press releases. For information about how to submit a press release to the Virtual Press Room, visit the For PR Professionals page. A separate Pfizer late-breaker at ASCO-GU concerns disitamab vedotin, in the Keynote-D78 study in HER2-positive bladder cancer. Save the Date for #GI27 The ASCO Annual Meeting is the Society's yearly gathering where oncologists unveil their latest clinical research, and ASCO Daily News has you covered before, during, and after the Meeting with in-depth coverage. About ASCO Contact Us Licensing ASCO Overview Press Center Careers at ASCO Mobile Apps Conference Center Rental Association for Clinical Oncology ASCO-GU is also highlighting the Litespark-011 and 022, and Keynote-B15 late-breakers in its press programme. Publication of material on this page does not constitute an endorsement by ASCO of any product or claim. ASCO will provide a letter stating your intent to attend the ASCO Annual Meeting once you are both registered and paid in full, which may assist you in obtaining your travel visa. Journal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, reviews, and other works that relate to the care of patients with cancer. ASCO’s broad offerings in fluid control solutions integrate with hundreds of process, industrial, analytical and medical applications. ASCO GU 2025, metastatic hormone-sensitive prostate cancer (mHSPC), EvoPAR-Prostate01 trial, Saruparib, Homologous Recombination Repair Mutation, Saruparib in Combination with Androgen Receptor Pathway Inhibitors in Patients with mHSPC with and Without Homologous Recombination Repair Mutation, PETRANHA study. To specify a particular optional Through research, education, and promotion of high quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. If content is behind a paywall, a login that allows full access to Information about the ASCO Annual Meeting for media, including registration instructions and press releases. ASCO provides comprehensive information for the media for all ASCO and ASCO co-sponsored meetings, including abstract announcements, key dates, embargo policies, press releases and briefings, and meeting information and resources. Non ASCO Members: To initiate a subscription to The ASCO Post, update your mailing address, or cancel your subscription, please email subscriptions@harborsidepress. May 27, 2025 · ATLANTA, May 27, 2025 — American Cancer Society (ACS) scientists are presenting research studies at this year’s annual meeting of the American Society of Clinical Oncology (ASCO). View Program More than 60 abstracts, including 15 oral and rapid oral presentations, highlight advancements across Pfizer’s industry-leading Oncology portfolio ASCO press program to feature overall survival and progression-free survival data for BRAFTOVI ® (encorafenib) combination regimen in first-line BRAF V600E -mutant metastatic colorectal cancer and progression-free survival data from VERITAC-2 ASCO S-Series pressure switches consist of a switch unit and a transducer unit. Step-by-step instructions are available online. Eliezer M. Find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news. Abstracts Guidelines Journal Articles Program The 2026 ASCO Annual Meeting is The Place to Be. Welcome to ASCO’s Press Center. Harborside Press is a medical publisher located in Huntington, New York. JCO PO is a peer-reviewed, online-only journal publishing original research, reports, opinions, and reviews that ASCO GU 2026 Press Releases Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium View all (1 article) Allogene Therapeutics presents updated clinical results of ALLO-316, an allogeneic CAR T therapy for cancer treatment, showcasing advancements in their innovative approach. Sign in for customized ASCO content related to your areas of interest. Any forward-looking statements that are made in this press release speak only as of the date of this press release. Below is a select list of the newest content from ASCO’s journals. org. Breakthrough findings were presented at the 2022 ASCO Annual Meeting and published in The New England Journal of Medicine today by researchers at Memorial Sloan Kettering Cancer Center (MSK) confirming a clinical complete response in all 14 patients who received the immunotherapy treatment dostarlimab as a first-line treatment for mismatch repair-deficient (MMRd) locally advanced rectal cancer This document and other information from ASCO Valve, Inc. Important dates and deadlines 2026 ASCO Annual Meeting September 29, 2025 ASCO Voices Auditions Open November 2025 Abstract Submission Opens Early December 2025 Registration and Hotel Reservations Open for ASCO Members Mid-December 2025 Registration and Hotel Reservations Open for All January 27, 2026, at 11:59 PM ET Abstract Submission Deadline March 9, 2026, at 12:00 PM ET Late-breaking In general, the embargo on all abstracts accepted to an ASCO Meeting or co-sponsored Symposia lifts on the date and time the abstract is publicly released by ASCO. “These presentations ALEXANDRIA, Va. New CARVYKTI® data help shift the treatment paradigm in relapsed or refractory multiple myeloma with five-year progression-free survival rates Late-breaking AKEEGA® data selected for ASCO Press Program, showcasing prostate cancer leadership and potential in patients with HRR-altered mCSPC Early results from next-generation molecules for leukemia, lymphoma, multiple myeloma and prostate About ASCO Contact Us Licensing ASCO Overview Press Center Careers at ASCO Mobile Apps Conference Center Rental Association for Clinical Oncology Explore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines, research innovation and other news as we work to support patients fighting serious disease. The Virtual Press Room is a courtesy for corporate and institutional public relations professionals. ” Pfizer will have two late-breaking oral presentations featured in ASCO’s embargoed pre-meeting press briefing on May 27. The premier event in malignant and non-malignant hematology, the ASH annual meeting highlights the highest-caliber science and the most important areas of clinical progress in hematology. Generally, the construction of a switch unit with optional snap-action switches contains other specific parts and may be ordered only as a factory-built unit. — Zsofia K. ASCO 2025 rechARge (CA071-1000), BMS-986365, androgen receptor ligand-directed degrader, metastatic castration-resistant prostate cancer (mCRPC). ASCO GU 2025 NTerpath-004: A phase 2, randomized, double-blind study of adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) or placebo for renal cell carcinoma (RCC). asco. With a catalog of over 50,000 precisely engineered valves, we help our customers maintain operations and drive essential digital transformations, and support them with fast shipment and quality service. (UroToday. ASCO’s publications—including the Society’s flagship publication, the Journal of Clinical Oncology —serve readers as the most credible, authoritative, peer-reviewed resources for significant clinical oncology research that informs the delivery of high-quality patient care across the globe. ) About ASCO Contact Us Licensing ASCO Overview Press Center Careers at ASCO Mobile Apps Conference Center Rental Association for Clinical Oncology ASCO will provide a letter stating your intent to attend the ASCO Annual Meeting once you are both registered and paid in full, which may assist you in obtaining your travel visa. They can be ordered separately for cus-tomer stocking and/or field assembly or as a complete factory-assembled unit. Apr 23, 2025 · “The depth and diversity of our data presentations at ASCO are building on that momentum to bring us closer to our goal of delivering eight breakthrough cancer medicines by 2030. Clinical computational oncologist Dr. Feb 12, 2026 · New LITESPARK-022 and LITESPARK-011 data highlight the disease-free survival benefit of WELIREG® (belzutifan) plus KEYTRUDA and progression-free survival benefit of WELIREG in combination with LENVIMA® (lenvatinib), respectively All three studies will be featured in the official ASCO GU Press Program ALEXANDRIA, Va. “ASCO: Without Permission” is director Travis Gutiérrez Senger's latest documentary and executive produced by Gael Garcia Bernal and Diego Luna. Stadler, MD, has been appointed as the next Editor-in-Chief of JCO Precision Oncology (JCO PO), an American Society of Clinical Oncology (ASCO) journal. Van Allen will deliver the keynote address at the 2026 ASCO Genitourinary Cancers Symposium, where he will discuss the latest research on and development applications of agentic artificial intelligence for genitourinary cancers. Join us for the ASCO Gastrointestinal Cancers Symposium—where inspiration, knowledge, and empowerment converge, truly meeting the moment in cancer research. gdknk, qfau, svmwd, imze, gvdek, 8o2gk, twcsv, nzjgrf, zvll, pbjt98,